Nadja Dorfs-Blagitko
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts.
Journal: Leukemia
Published: October 18, 2022
Correction to: Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients.
Journal: Clinical epigenetics
Published: April 29, 2021
Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy.
Journal: Annals of hematology
Published: September 13, 2016
Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesis.
Journal: Leukemia research
Published: March 28, 2016
Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.
Journal: Oncotarget
Published: October 28, 2015
Tracing the development of acute myeloid leukemia in CBL syndrome.
Journal: Blood
Published: February 05, 2014
Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat.
Journal: PloS one
Published: April 10, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026